Arbutus Biopharma Corp (ABUS)
3.955
+0.10
(+2.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.955
0.00 (0.00%)
After-Hours: 19:13
Arbutus Biopharma Shareholders Equity (Quarterly): 122.45M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 122.45M |
| March 31, 2024 | 114.64M |
| December 31, 2023 | 106.02M |
| September 30, 2023 | 119.34M |
| June 30, 2023 | 134.69M |
| March 31, 2023 | 143.92M |
| December 31, 2022 | 136.85M |
| September 30, 2022 | 145.52M |
| June 30, 2022 | 153.14M |
| March 31, 2022 | 165.84M |
| December 31, 2021 | 169.44M |
| September 30, 2021 | 130.14M |
| June 30, 2021 | 100.83M |
| March 31, 2021 | 114.15M |
| December 31, 2020 | 101.97M |
| September 30, 2020 | 97.34M |
| June 30, 2020 | 65.51M |
| March 31, 2020 | 73.26M |
| December 31, 2019 | 72.74M |
| September 30, 2019 | 83.64M |
| June 30, 2019 | 164.47M |
| March 31, 2019 | 181.21M |
| December 31, 2018 | 200.23M |
| September 30, 2018 | 215.27M |
| June 30, 2018 | 238.07M |
| Date | Value |
|---|---|
| March 31, 2018 | 232.42M |
| December 31, 2017 | 182.47M |
| September 30, 2017 | 167.39M |
| June 30, 2017 | 175.79M |
| March 31, 2017 | 189.10M |
| December 31, 2016 | 203.00M |
| September 30, 2016 | 416.62M |
| June 30, 2016 | 431.32M |
| March 31, 2016 | 538.08M |
| December 31, 2015 | 547.68M |
| September 30, 2015 | 553.81M |
| June 30, 2015 | 588.50M |
| March 31, 2015 | 593.69M |
| December 31, 2014 | 88.04M |
| September 30, 2014 | 95.50M |
| June 30, 2014 | 105.14M |
| March 31, 2014 | 105.48M |
| December 31, 2013 | 59.19M |
| September 30, 2013 | 29.84M |
| June 30, 2013 | 34.02M |
| March 31, 2013 | 37.87M |
| December 31, 2012 | 40.92M |
| September 30, 2012 | 0.3141M |
| June 30, 2012 | 3.540M |
| March 31, 2012 | 5.386M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
65.51M
Minimum
Jun 2020
169.44M
Maximum
Dec 2021
119.36M
Average
119.34M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| GlycoMimetics Inc | 20.06M |
| FibroGen Inc | -232.34M |
| Cidara Therapeutics Inc | 130.94M |
| Cue Biopharma Inc | 21.62M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.04M |
| Total Liabilities (Quarterly) | 37.59M |
| Current Ratio | 6.560 |